Tracking target lesions is crucial for evaluating the efficacy of a given treatment. Changes in the size or number of these lesions can indicate whether a treatment is working, stable, or if the disease is progressing. This information helps oncologists make informed decisions about continuing, altering, or stopping a particular treatment regimen.